Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) ...
Sep 5, 2023
0
2